Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, March 28, 2024 | Back issues
Courthouse News Service Courthouse News Service

FDA Delays Safety Reporting for New Drugs for 6 Months

WASHINGTON (CN) - The Food and Drug Administration will delay for 6 months enforcement of safety reporting requirements for investigational new drugs and bioavailability and bioequivalence studies.

The agency has issued a guide informing sponsors and investigators that the agency intends to exercise enforcement discretion regarding the reporting requirements in the final rule, "Safety Reporting Requirements for Human Drug and Biological Products and Safety Reporting Requirements for Studies in Humans", until Sept. 28, 2011.

Click on the document icon for this regulation and others.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...